FDA Clears Imagyn Device for Marketing

Imagyn Medical Inc. said Thursday it has received clearance from the Food and Drug Administration to market its MicroSpan sheath, which will permit physicians to diagnose and treat uterine disorders with minimally invasive procedures. Imagyn Medical designs, develops and markets “micro-invasive” device systems for the diagnosis and treatment of gynecological and reproductive disorders.